OOIR: Observatory of International Research

Papers

(The H4-Index of Radiation Oncology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)	90
Efficacy and safety of tyrosine kinase inhibitors with thoracic radiotherapy for patients with oncogene-mutated non-small cell lung cancer: a meta-analysis	84
Pamiparib as consolidation treatment after concurrent chemoradiotherapy of limited-stage small cell lung cancer: a single-arm, open-label phase 2 trial	83
Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer	75
CT-based auto-segmentation of multiple target volumes for all-in-one radiotherapy in rectal cancer patients	75
Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study	53
Dosimetric comparison of two dose expansion methods in intensity modulated radiotherapy for breast cancer	38
Comparison of deep learning networks for fully automated head and neck tumor delineation on multi-centric PET/CT images	38
The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma	37
CircRNA_101491 regulated the radiation sensitivity of esophageal squamous cell carcinomas via sponging miR-125a-5p	36
Radiotherapy refusal in breast cancer with breast-conserving surgery	34
A multifunctional targeted nano-delivery system with radiosensitization and immune activation in glioblastoma	34
Knowledge-based DVH estimation and optimization for breast VMAT plans with and without avoidance sectors	34
Compliance of volunteers in a fully-enclosed patient rotation system for MR-guided radiation therapy: a prospective study	32
Outcome of patients with soft tissue sarcomas of the extremities and trunk treated by (neo)adjuvant intensity modulated radiation therapy with curative intent	31
Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov	30
Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy	29
125I seed brachytherapy for non-central pelvic recurrence of cervical cancer after external beam radiotherapy	28
Using meta-analysis and CNN-NLP to review and classify the medical literature for normal tissue complication probability in head and neck cancer	28
A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy	27
Linear accelerator-based stereotactic radiotherapy for brain metastases, including multiple and large lesions, carries a low incidence of acute toxicities: a retrospective analysis	26
Biological target volume based on fluorine-18-fluorode-oxyglucose positron emission tomography/computed tomography imaging: a spurious proposition?	25
Online adaptive stereotactic body radiotherapy for localized prostate cancer in patients with lower urinary tract symptoms and/or prostate hyperplasia (X-SMILE)	25
Clinical features and risk factors for interstitial lung disease spreading in low-dose irradiated areas after definitive radiotherapy with or without durvalumab consolidation therapy for patients with	25
Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models	24

A survey of cancer patients’ interest in undertaking exercise to promote relaxation during radiotherapy for breast cancer and metastatic cancer	24
Correction: Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas	24
Preliminary study of feasibility of surface-guided radiotherapy with concurrent tumor treating fields for glioblastoma: region of interest	24